Fetal chromosome X & Y aneuploidy risk:Likelihood:Pt:Plas.cfDNA:Qn:Dosage of chromosome
specific cf DNA - CISMeF
Fetal chromosome X & Y aneuploidy risk:Likelihood:Pt:Plas.cfDNA:Qn:Dosage of chromosome
specific cf DNALOINC code
Preferred Label : Fetal chromosome X & Y aneuploidy risk:Likelihood:Pt:Plas.cfDNA:Qn:Dosage of chromosome
specific cf DNA;
LOINC status : ACTIVE;
LOINC display name : Chr X and Y aneuploidy risk Dosage of chromosome-specific cfDNA Qn (cfDNA);
LOINC long common name : Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA
by Dosage of chromosome-specific cfDNA;
LOINC short name : Fet Chr X Y aneup risk Plas.cfDNA Qn;
LOINC description : The probability risk for sex chromosome (X & Y) aneuploidy can be determined based
on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma,
the mother's current age and gestational age. The ccf DNA includes both fetal and
maternal DNA. This code is based, but not limited in use to, the submitter's test,
Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the
risk determination of fetal aneuploidy as well as trisomy 13, 18 and 21 in women with
singleton pregnancies of at least 10 weeks gestational age.;